HER2-positive breast cancer: current treatment strategies

MeSH terms

• Antibodies, Monoclonal / adverse effects
• Antibodies, Monoclonal / therapeutic use*
• Antibodies, Monoclonal, Humanized
• Antineoplastic Agents, Hormonal / therapeutic use
• Antineoplastic Combined Chemotherapy Protocols / therapeutic use
• Breast Neoplasms / drug therapy*
• Breast Neoplasms / enzymology*
• Breast Neoplasms / genetics
• Breast Neoplasms / pathology
• Chemotherapy, Adjuvant
• Female
• Gene Expression Regulation, Enzymologic
• Gene Expression Regulation, Neoplastic
• Heart Failure / chemically induced
• Humans
• Immunohistochemistry
• In Situ Hybridization, Fluorescence
• Neoadjuvant Therapy
• Neoplasm Metastasis
• Observer Variation
• Patient Selection*
• Protein Kinase Inhibitors / adverse effects
• Protein Kinase Inhibitors / therapeutic use*
• Receptor, ErbB-2 / analysis*
• Receptor, ErbB-2 / genetics
• Reproducibility of Results
• Trastuzumab
• Treatment Outcome
• Up-Regulation
• Ventricular Dysfunction, Left / chemically induced